Home / NCNA : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does NCNA make money? Does NCNA have pricing power? What's the Earnings Whisper? Will NCNA profit more as the business scales? What is NCNA's management track record? Is NCNA's current price justified?

NuCana plc

$1.32 -$2.32 (-63.74%)

NASDAQ · 14 Sep 2026 20:00 UTC

Previous Close

$1.32

Day Range

$1.31$1.37

Year Range

$1.21$7.22

Market Cap

8.02M

AVG Volume

58.47K

Trailing/Forward PE

-0.33/-

PEG ratio

-0

Dividend Yield

Next Earnings Date

2026-11-12

Primary Exchange

NASDAQ

Revenue (GBP) · TTM

NCNA Revenue (GBP) · TTM by quarter
Period	Revenue (GBP) · TTM
26 Q2	0
26 Q1	0
25 Q4	0
25 Q3	0
25 Q2	0
25 Q1	0
24 Q4	0
24 Q3	0
24 Q2	0
24 Q1	0

Net Income (GBP) · TTM

NCNA Net Income (GBP) · TTM by quarter
Period	Net Income (GBP) · TTM
26 Q2	-9.73M
26 Q1	-30.75M
25 Q4	-29.35M
25 Q3	-27.52M
25 Q2	-31.75M
25 Q1	-14.63M
24 Q4	-19M
24 Q3	-26M
24 Q2	-28.18M
24 Q1	-26.6M

Operating Income (GBP) · TTM

NCNA Operating Income (GBP) · TTM by quarter
Period	Operating Income (GBP) · TTM
26 Q2	-13.3M
26 Q1	-21.68M
25 Q4	-20.11M
25 Q3	-16.32M
25 Q2	-20.87M
25 Q1	-17.39M
24 Q4	-22.81M
24 Q3	-31.05M
24 Q2	-33.98M
24 Q1	-31.91M

EBITDA (GBP) · TTM

NCNA EBITDA (GBP) · TTM by quarter
Period	EBITDA (GBP) · TTM
26 Q2	-14.37M
26 Q1	-22.55M
25 Q4	-20.56M
25 Q3	-18.94M
25 Q2	-20.4M
25 Q1	-16.98M
24 Q4	-22.48M
24 Q3	-29.33M
24 Q2	-33.04M
24 Q1	-30.47M

Cash Flows (GBP) · TTM

NCNA Cash Flows (GBP) · TTM by quarter
Period	Cash Flows (GBP) · TTM
26 Q2	-5.15M
26 Q1	-7.77M
25 Q4	-7.66M
25 Q3	-13.97M
25 Q2	-19.86M
25 Q1	-16.59M
24 Q4	-19.41M
24 Q3	-12.08M
24 Q2	-17.67M
24 Q1	-22.39M

EPS (GBP) · TTM

NCNA EPS (GBP) · TTM by quarter
Period	EPS (GBP) · TTM
26 Q2	-2.97
26 Q1	-33.32
25 Q4	-134.61
25 Q3	-133.93
25 Q2	-134.68
25 Q1	-105.07
24 Q4	-4.12
24 Q3	-5.5
24 Q2	-5.87
24 Q1	-5.37

Expenses (GBP) · TTM

NCNA Expenses (GBP) · TTM by quarter
Period	Expenses (GBP) · TTM
26 Q2	14.82M
26 Q1	23.05M
25 Q4	21.03M
25 Q3	19.45M
25 Q2	20.99M
25 Q1	17.68M
24 Q4	23.3M
24 Q3	30.22M
24 Q2	33.96M
24 Q1	31.44M

Shares Outstanding · TTM

NCNA Shares Outstanding · TTM by quarter
Period	Shares Outstanding · TTM
26 Q2	-3.67M
26 Q1	-11.66M
25 Q4	-10.03M
25 Q3	-9.12M
25 Q2	-8.6M
25 Q1	-1.28M
24 Q4	-1.65M
24 Q3	-2.45M
24 Q2	-2.95M
24 Q1	-3.34M

Employee Count

NCNA Employee Count by quarter
Period	Employee Count
2025	10
2024	20
2023	25
2022	28
2021	31
2020	27
2019	31
2018	24
2017	20

Free Cash Flow Yield

NCNA Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-126.2%
Sep 26	-126.17%
Sep 26	-118.9%
Aug 26	-94.69%
Aug 26	-110.53%
Aug 26	-104.83%
Aug 26	-171.38%
Jul 26	-190.69%
Jul 26	-192.78%
Jul 26	-190.33%
Jul 26	-186.7%
Jul 26	-183.28%
Jun 26	-158.99%
Jun 26	-129.14%
Jun 26	-128.36%
Jun 26	-127.74%
May 26	-107.84%
May 26	-124.17%
May 26	-114.12%
May 26	-118.92%
May 26	-227.92%
Apr 26	-248.16%
Apr 26	-226.93%
Apr 26	-258.15%
Apr 26	-306.47%
Mar 26	-357.87%
Mar 26	-305.53%
Mar 26	-261.13%
Mar 26	-234.59%
Feb 26	-235.82%
Feb 26	-242.52%
Feb 26	-243.34%
Feb 26	-231.67%
Jan 26	-205.97%
Jan 26	-158.12%
Jan 26	-152.68%
Jan 26	-150.26%
Jan 26	-139.68%
Dec 25	-154.07%
Dec 25	-141.94%
Dec 25	-135.8%
Dec 25	-120.78%
Nov 25	-116.83%
Nov 25	-141.38%
Nov 25	-145.95%
Nov 25	-686.76%
Oct 25	-627.55%
Oct 25	-599.86%
Oct 25	-508.32%
Oct 25	-481.05%
Oct 25	-552.86%
Sep 25	-641.49%
Sep 25	-700.98%
Sep 25	-674.76%
Sep 25	-903.5%
Aug 25	-812.67%
Aug 25	-754.49%
Aug 25	-19861.96%
Aug 25	-11417.09%
Aug 25	-9279.48%
Jul 25	-6162.41%
Jul 25	-7690.48%
Jul 25	-7344.55%
Jul 25	-6961.88%
Jun 25	-4363.8%
Jun 25	-3675.66%
Jun 25	-3228.45%
Jun 25	-7408.8%
May 25	-65.34%
May 25	-61.07%
May 25	-51.99%
May 25	-54.29%
May 25	-4.94%
Apr 25	-4.15%
Apr 25	-2.64%
Apr 25	-2.99%
Apr 25	-2.79%
Mar 25	-1.73%
Mar 25	-2.8%
Mar 25	-2.13%
Mar 25	-1.81%
Feb 25	-1.62%
Feb 25	-1.45%
Feb 25	-1.73%
Feb 25	-1.58%
Jan 25	-1.52%
Jan 25	-1.38%
Jan 25	-1.33%
Jan 25	-1.35%
Jan 25	-1.18%
Dec 24	-1.11%
Dec 24	-1.3%
Dec 24	-1.24%
Dec 24	-1.19%
Nov 24	-1.22%
Nov 24	-1.99%
Nov 24	-1.65%
Nov 24	-1.67%
Nov 24	-1.64%
Oct 24	-1.41%

Price to Book

NCNA Price to Book by quarter
Period	Price to Book
Sep 26	0.2
Sep 26	0.2
Sep 26	0.22
Aug 26	0.27
Aug 26	0.23
Aug 26	0.24
Aug 26	0.2
Jul 26	0.18
Jul 26	0.18
Jul 26	0.18
Jul 26	0.19
Jul 26	0.19
Jun 26	0.22
Jun 26	0.27
Jun 26	0.27
Jun 26	0.27
May 26	0.32
May 26	0.28
May 26	0.3
May 26	0.26
May 26	0.24
Apr 26	0.22
Apr 26	0.24
Apr 26	0.21
Apr 26	0.18
Mar 26	0.15
Mar 26	0.18
Mar 26	0.21
Mar 26	0.23
Feb 26	0.23
Feb 26	0.22
Feb 26	0.22
Feb 26	0.23
Jan 26	0.26
Jan 26	0.34
Jan 26	0.35
Jan 26	0.36
Jan 26	0.39
Dec 25	0.35
Dec 25	0.38
Dec 25	0.4
Dec 25	0.45
Nov 25	0.46
Nov 25	0.38
Nov 25	0.37
Nov 25	0.39
Oct 25	0.43
Oct 25	0.45
Oct 25	0.53
Oct 25	0.56
Oct 25	0.49
Sep 25	0.42
Sep 25	0.38
Sep 25	0.4
Sep 25	0.3
Aug 25	0.33
Aug 25	0.36
Aug 25	0.02
Aug 25	0.03
Aug 25	0.04
Jul 25	0.06
Jul 25	0.05
Jul 25	0.05
Jul 25	0.06
Jun 25	0.09
Jun 25	0.11
Jun 25	0.12
Jun 25	0.05
May 25	4.99
May 25	5.34
May 25	6.27
May 25	6
May 25	65.96
Apr 25	78.58
Apr 25	123.29
Apr 25	109
Apr 25	116.69
Mar 25	188.31
Mar 25	116.28
Mar 25	130.68
Mar 25	153.12
Feb 25	171.46
Feb 25	191.89
Feb 25	160.72
Feb 25	175.68
Jan 25	182.98
Jan 25	201.27
Jan 25	208.26
Jan 25	205.74
Jan 25	234.44
Dec 24	250.93
Dec 24	214.13
Dec 24	223.72
Dec 24	233.78
Nov 24	226.91
Nov 24	234.16
Nov 24	281.66
Nov 24	278.8
Nov 24	284.36
Oct 24	329.5

No video analysis for this stock yet. Request one from our team.

News: NCNA

globenewswire.com · 13 Aug 2026

NuCana Reports Second Quarter 2026 Financial Results and Provides Business Update

Final Data from Phase 2 Expansion Study of NUC-7738 Remains on Track for 2026 Advancing Additional Indications and Combination Strategies for NUC-7738 Cash Runway Expected to Extend into 2029 EDINBURGH, United Kingdom, Aug. 13, 2026 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) today announced financial results for the second quarter ended June 30, 2026 and provided an update on its clinical development program with its two lead anti-cancer medicines. “NuCana continues to build momentum as we advance NUC-7738 closer to several important clinical and regulatory milestones,” said Hugh S.

AI Analysis

NuCana plc

Video analysis: NCNA

News: NCNA

NuCana Reports Second Quarter 2026 Financial Results and Provides Business Update

Similar companies